Regulation of Exocytosis in the Post-Ischemic Myocardium
Regulation of Exocytosis in the Post-Ischemic Myocardium
批准号:
7160736
负责人:
CHARLES J LOWENSTEIN
金额:
$40.84万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-04-01 至 2011-03-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Ischemia and reperfusion trigger the rapid release of endothelial granules containing mediators of vascular
inflammation and thrombosis, including P-selectin, interleukin-8, and von Willebrand factor. P-selectin is
translocated from the interior of the endothelial cell to the exterior surface, where it mediates leukocyte
adherence to the endothelial wall. Interleukin-8 is released into the blood, where it can activate leukocytes,
increasing the interactions between leukocytes and endothelial cells. Endothelial exocytosis is thus an early step
in leukocyte trafficking into the ischemic myocardium.
The over-all goal of this project is to characterize the mechanisms by which exocytosis of endothelial granules
leads to injury in the post-ischemic myocardium. We have previously identified components of the exocytic
machinery of endothelial cells. We subsequently discovered that nitric oxide inhibits vascular inflammation by
inhibiting specific proteins that mediate exocytosis. We then developed a novel polypeptide that interferes with
the exocytic machinery, inhibits exocytosis, and decreases vascular inflammation. We now propose to extend
these studies to explore the mechanisms of exocytosis in post-ischemic myocardium.
We first plan to study how hypoxia activates exocytosis. We will focus on the role of signaling
intermediates such as calcineurin which regulate exocytosis by post-translational modifications of the exocytic
machinery. We will then characterize the role of one particular component of the exocytic machinery in postischemic
inflammation. We will finally define a novel mechanism which regulates a major stress response
pathway in hypoxic endothelial cells. Each of these aims includes a wide range of studies, from recombinant
proteins to transduced cells to animal experiments. These studies will increase our understanding of the
molecular mechanisms regulating endothelial exocytosis, and will lead to novel therapies that inhibit
inflammation and injury to the post-ischemic myocardium.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Model system of oral contraceptive-induced VTE: integrating genomic, transcriptomic, and proteomic discovery with functional biology
-
批准号:10418628
-
项目类别:
-
资助金额:$62.68万
-
财政年份:2020
-
负责人:CHARLES J LOWENSTEIN
-
依托单位:
Model system of oral contraceptive-induced VTE: integrating genomic, transcriptomic, and proteomic discovery with functional biology
-
批准号:10164668
-
项目类别:
-
资助金额:$67.29万
-
财政年份:2020
-
负责人:CHARLES J LOWENSTEIN
-
依托单位:
Population genomic variation, functional biology, and the risk of venous thrombosis
-
批准号:9750789
-
项目类别:
-
资助金额:$71.08万
-
财政年份:2017
-
负责人:CHARLES J LOWENSTEIN
-
依托单位:
VAMP8 regulates endothelial exocytosis and microvascular obstruction
-
批准号:8903561
-
项目类别:
-
资助金额:$38.38万
-
财政年份:2014
-
负责人:CHARLES J LOWENSTEIN
-
依托单位:
Novel Regulators of Endothelial Exocytosis
-
批准号:8445932
-
项目类别:
-
资助金额:$26.86万
-
财政年份:2013
-
负责人:CHARLES J LOWENSTEIN
-
依托单位:
Novel Regulators of Endothelial Exocytosis
-
批准号:8604406
-
项目类别:
-
资助金额:$15.04万
-
财政年份:2013
-
负责人:CHARLES J LOWENSTEIN
-
依托单位:
Exocytosis and Vascular Inflammation
-
批准号:7115398
-
项目类别:
-
资助金额:$31.93万
-
财政年份:2004
-
负责人:CHARLES J LOWENSTEIN
-
依托单位:
Regulation of Vascular Inflammation
-
批准号:6889495
-
项目类别:
-
资助金额:$24.53万
-
财政年份:2004
-
负责人:CHARLES J LOWENSTEIN
-
依托单位:
Exocytosis and Vascular Inflammation
-
批准号:6847671
-
项目类别:
-
资助金额:$32.7万
-
财政年份:2004
-
负责人:CHARLES J LOWENSTEIN
-
依托单位:
Regulation of Vascular Inflammation
-
批准号:7426027
-
项目类别:
-
资助金额:$5.2万
-
财政年份:2004
-
负责人:CHARLES J LOWENSTEIN
-
依托单位:
Regulation of Vascular Inflammation
-
批准号:7054712
-
项目类别:
-
资助金额:$31.93万
-
财政年份:2004
-
负责人:CHARLES J LOWENSTEIN
-
依托单位:
Regulation of Vascular Inflammation
-
批准号:6773530
-
项目类别:
-
资助金额:$40.88万
-
财政年份:2004
-
负责人:CHARLES J LOWENSTEIN
-
依托单位:
Exocytosis and Vascular Inflammation
-
批准号:6951583
-
项目类别:
-
资助金额:$32.7万
-
财政年份:2004
-
负责人:CHARLES J LOWENSTEIN
-
依托单位:
Exocytosis and Vascular Inflammation
-
批准号:7278288
-
项目类别:
-
资助金额:$31.01万
-
财政年份:2004
-
负责人:CHARLES J LOWENSTEIN
-
依托单位:
Regulation of Vascular Inflammation
-
批准号:7228479
-
项目类别:
-
资助金额:$31.01万
-
财政年份:2004
-
负责人:CHARLES J LOWENSTEIN
-
依托单位:
Regulating NOS2 in ischemic & post-ischemic myocardium
-
批准号:6803071
-
项目类别:
-
资助金额:$29.71万
-
财政年份:2003
-
负责人:CHARLES J LOWENSTEIN
-
依托单位:
Regulation of Weibel-Palade Body Secretion in AGA
-
批准号:6739499
-
项目类别:
-
资助金额:$34.83万
-
财政年份:2003
-
负责人:CHARLES J LOWENSTEIN
-
依托单位:
Regulating NOS2 in ischemic & post-ischemic myocardium
-
批准号:6654181
-
项目类别:
-
资助金额:$29.71万
-
财政年份:2002
-
负责人:CHARLES J LOWENSTEIN
-
依托单位:
Regulating NOS2 in ischemic & post-ischemic myocardium
-
批准号:6494012
-
项目类别:
-
资助金额:$29.71万
-
财政年份:2001
-
负责人:CHARLES J LOWENSTEIN
-
依托单位:
MEDIATORS OF ACCELERATED GRAFT ARTERIOSCLEROSIS
-
批准号:6448218
-
项目类别:
-
资助金额:$49.81万
-
财政年份:2001
-
负责人:CHARLES J LOWENSTEIN
-
依托单位:
国内基金
海外基金
登录
查看更多内容
热应激通过Ca²⁺/Calcineurin/DRP1轴诱导心肌损伤与室性心律失常的分子机制研究
-
批准号:JCZRQNB202600378
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
Ca2+驱动的Calcineurin/LATS1信号重塑糖有氧氧化进程在B1AR自身抗体诱导心房重构中的机制研究
-
批准号:--
-
项目类别:青年科学基金项目
-
资助金额:--
-
批准年份:2024
-
负责人:孙华鑫
-
依托单位:
乳酸通过Ca2+/Calcineurin/TFEB信号轴在氧化应激诱导视网膜退行性变中的作用机制研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:--
-
批准年份:2024
-
负责人:韩小建
-
依托单位:
Ca2+驱动的Calcineurin/LATS1信号重塑糖有氧氧化进程在β1AR自身抗体诱导心房重构中的机制研究
-
批准号:
-
项目类别:青年科学基金项目
-
资助金额:--
-
批准年份:2024
-
负责人:孙华鑫
-
依托单位:
STING-Ca2+-Calcineurin 负反馈环在机体维
持抗病毒天然免疫稳态中的机制研究
-
批准号:Q24H100001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:王宁
-
依托单位:
神经介素U通过NMUR1/calcineurin/NAFT 通路介导ARDS神经免疫环路调控的研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2022
-
负责人:戚迪
-
依托单位:
神经分泌NMU通过NMUR1/calcineurin/NFAT通路调控ILC2介导的ARDS免疫炎症的效应及机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:王导新
-
依托单位:
Rcan2抑制Calcineurin活性决定尾鳍极性再生的机制研究
-
批准号:32170853
-
项目类别:面上项目
-
资助金额:57万元
-
批准年份:2021
-
负责人:陆辉强
-
依托单位:
Calcineurin/CRTC2轴介导的CD206+MerTK+巨噬细胞-肝细胞互作重塑移植肝糖稳态研究
-
批准号:82171757
-
项目类别:面上项目
-
资助金额:54万元
-
批准年份:2021
-
负责人:凌琪
-
依托单位:
甲基转移酶 SETD2 调控 Calcineurin 信号抑制线粒体分裂在胶质母细胞瘤细胞增殖与侵袭中的作用及机制
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:
-
依托单位: